Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nihar Desai

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|June 10, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous ThromboembolismNihar Desai
Bone Marrow Transplantation|February 4, 2026
PTCy versus ATG in HLA-matched sibling donor allogeneic transplantation: Comment on: Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working PartyNihar Desai, Auro Viswabandya
Current Hematologic Malignancy Reports|August 11, 2025
Allogeneic Transplant for CMMLNico Gagelmann, Nihar Desai
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 21, 2025
Recurrent Hypoglycemia during Sorafenib Maintenance Post-Allogeneic Hematopoietic Stem Cell TransplantationNihar Desai, Auro Viswabandya
Haematologica|September 11, 2025
HLA matching in the PTCy era: the locus still matters. Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationNihar Desai, Jonas Mattsson
Transplantation and Cellular Therapy|June 4, 2026
Toward a Standardized Definition of Reduced-Dose Post-Transplant Cyclophosphamide in Allogeneic Hematopoietic Cell TransplantationNihar Desai, Jonas Mattsson
Haematologica|March 26, 2026
Do myelodysplasia-related gene mutations alter transplant decisions in <i>NPM1-</i>mutated acute myeloid leukemia? Comment on: "Prognostic implications of myelodysplasiarelated gene mutations in <i>NPM1</i>-mutated acute myeloid leukemia: a systematic review and meta-analysis"Nihar Desai, Jonas Mattsson
JAMA Internal Medicine|December 27, 2022
A Peculiar ST Elevation Mimicking STEMIJose Victor Jimenez, Soumya Banna, Nihar Desai
The New England Journal of Medicine|October 1, 2025
Cyclophosphamide and Cyclosporin for GVHD PreventionNihar Desai, Jonas Mattsson, Arjun D Law
Bone Marrow Transplantation|June 24, 2026
Reconsidering the role of bone marrow as a graft source in haploidentical allogeneic hematopoietic cell transplantationNihar Desai, Jonas Mattsson, Arjun D Law
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|June 10, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous ThromboembolismNihar Desai
Bone Marrow Transplantation|February 4, 2026
PTCy versus ATG in HLA-matched sibling donor allogeneic transplantation: Comment on: Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working PartyNihar Desai, Auro Viswabandya
Current Hematologic Malignancy Reports|August 11, 2025
Allogeneic Transplant for CMMLNico Gagelmann, Nihar Desai
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 21, 2025
Recurrent Hypoglycemia during Sorafenib Maintenance Post-Allogeneic Hematopoietic Stem Cell TransplantationNihar Desai, Auro Viswabandya
Haematologica|September 11, 2025
HLA matching in the PTCy era: the locus still matters. Comment on: Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationNihar Desai, Jonas Mattsson
Transplantation and Cellular Therapy|June 4, 2026
Toward a Standardized Definition of Reduced-Dose Post-Transplant Cyclophosphamide in Allogeneic Hematopoietic Cell TransplantationNihar Desai, Jonas Mattsson
Haematologica|March 26, 2026
Do myelodysplasia-related gene mutations alter transplant decisions in <i>NPM1-</i>mutated acute myeloid leukemia? Comment on: "Prognostic implications of myelodysplasiarelated gene mutations in <i>NPM1</i>-mutated acute myeloid leukemia: a systematic review and meta-analysis"Nihar Desai, Jonas Mattsson
JAMA Internal Medicine|December 27, 2022
A Peculiar ST Elevation Mimicking STEMIJose Victor Jimenez, Soumya Banna, Nihar Desai
The New England Journal of Medicine|October 1, 2025
Cyclophosphamide and Cyclosporin for GVHD PreventionNihar Desai, Jonas Mattsson, Arjun D Law
Bone Marrow Transplantation|June 24, 2026
Reconsidering the role of bone marrow as a graft source in haploidentical allogeneic hematopoietic cell transplantationNihar Desai, Jonas Mattsson, Arjun D Law
Pageof 10